The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis
With multiple approved products, the field of gene therapies has gained substantial momentum over the last couple of decades; innovator companies are gradually progressing their proprietary therapy candidates with cautious optimismRoots Analysis is pleased to announce the publication of its recent study, titled, “Gene Therapy Market (3rd Edition), 2019-2030”.
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
The report features an extensive study of the current market landscape of gene therapies, primarily focusing on gene augmentation-based therapies, oncolytic viral therapies and genome editing therapies. The study also features an elaborate discussion on the future potential of this evolving market. In addition to other elements, the study includes:
A detailed review of the overall landscape of gene therapies and genome editing therapies.
A discussion on the various types of viral and non-viral vectors.
A world map representation, depicting the most active geographies, and a bull’s eye analysis, highlighting the distribution of clinical-stage pipeline candidates by phase of development, type of vector and type of therapy.
A discussion on the regulatory landscape related to gene therapies across various geographies.
Detailed profiles of marketed and phase II/III and gene therapies.
An elaborate discussion on the various commercialization strategies that can be adopted by drug developers for use across different stages of therapy development.
A review of various emerging technologies and therapy development platforms that are being used to design and manufacture gene therapies.
An in-depth analysis of the various patents that have been filed / granted related to gene therapies and genome editing therapies, since 2016.
An analysis of the various mergers and acquisitions that have taken place in this domain, highlighting the trend in the number of companies acquired between 2014-2019.
An analysis of the investments made at various stages of development in companies that are focused in this area, between 2014-2019.
An analysis of the big biopharma players engaged in this domain.
A case study on the prevalent and emerging trends related to vector manufacturing, with information on companies offering contract services for manufacturing vectors.
A discussion on the various operating models adopted by gene therapy developers for supply chain management.
An analysis of the various factors that are likely to influence the pricing of gene-based therapies.
A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
Key therapeutic areas
Autoimmune disorders
Cardiovascular diseases
Genetic disorders
Hematological disorders
Metabolic disorders
Ophthalmic disorders
Oncological disorders
Others
Type of vector
Adeno associated virus
Adenovirus
Herpes simplex virus type 1
Lentivirus
Plasmid DNA
Retrovirus
Vaccinia Virus
Type of therapy
Ex vivo
In vivo
Type of gene modification
Gene augmentation
Immunotherapy
Oncolytic therapy
Others
Route of administration
Intraarticular
Intracerebellar
Intramuscular
Intradermal
Intravenous
Intravitreal
Intravesical
Subretinal
Others
Key geographical regions
North America
Europe
Asia-Pacific
Transcripts of interviews held with the following senior level representatives of stakeholder companies
Adam Rogers (CEO, Hemera Biosciences)
Al Hawkins (CEO, Milo Biotechnology)
Buel Dan Rodgers (Founder & CEO, AAVogen)
Cedric Szpirer (Executive & Scientific Director, Delphi Genetics)
Christopher Reinhard (CEO and Chairman, Cardium Therapeutics)
Ryo Kubota (Chairman, President and Chief Executive Officer, Acucela)
Jeffrey Hung (CCO, Vigene Biosciences)
Marco Schmeer (Project Manager) & Tatjana Buchholz (Marketing Manager, PlasmidFactory)
Michael Triplett (CEO, Myonexus Therapeutics, acquired by Sarepta Therapeutics)
Robert Jan Lamers (CEO, Arthrogen)
Tom Wilton (Chief Business Officer, LogicBio Therapeutics)
Key companies covered in the report
Advantagene
Advaxis
BioMarin
bluebird bio
FKD Therapies
Freeline Therapeutics
GenSight Biologics
Gradalis
Inovio Pharmaceuticals
Marsala Biotech
Orchard Therapeutics
Pfizer
Sarepta Therapeutics
Spark Therapeutics
Tocagen
Transgene
uniQure Biopharma
VBL Therapeutics
ViroMed
For more information please click on the following link:
https://www.rootsanalysis.com/reports/view_document/gene-therapy-market-3rd-edition-2019-2030/268.html
Other Recent Offerings
1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030 (Focus on AAV, Adenoviral, Lentiviral, Retroviral, Plasmid DNA and Other Vectors)
2. CAR-T Therapies Market (2nd Edition), 2019-2030
3. Global T-Cell (CAR-T, TCR, and TIL) Therapy Market (4th Edition), 2019 – 2030
Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com
Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis
Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis here
News-ID: 2263223 • Views: …
More Releases from Roots Analysis
The Agricultural Biologicals Market Size Worth over USD 40 Billion in 2035 | Roo …
Global Agricultural Biologicals Market Overview
The agricultural biologicals market is a rapidly growing and dynamic industry that is poised to grow at a CAGR of 9.98% in the forecast period 2023-2035. The growth in the agricultural biologicals market size over the next decade is likely to be the result of a rise in the demand for organic food coupled with the growing focus on sustainable agriculture. Agricultural biologics include a vast…
The Lab Automation Market is anticipated to grow at a CAGR of around 15% by 2035 …
Owing to the advanced features and cost-saving potential of automation, stakeholders in the healthcare industry are adopting lab automation systems in order to get precise results and reduce deviations occurring due to manual handling
Roots Analysis has announced the addition of "Lab Automation Market, 2023-2035" report to its list of offerings.
The diverse applications of lab automation systems, including advanced data management, high reproducibility and increased productivity in the biotechnology…
The gene therapy market is projected to be worth USD 17.3 billion in 2035, growi …
Given the potential of gene therapies to permanently cure a diverse array of clinical conditions at the genetic level, the current pipeline is rapidly growing; a number of such therapies are currently being evaluated in late stages of development
London
Roots Analysis has announced the addition of "Gene Therapy Market" report to its list of offerings.
Post the emergence of blockbuster gene therapies, such as ZOLGENSMA® (for spinal muscular atrophy type…
The companion diagnostics development services market, is anticipated to grow at …
Roots Analysis has announced the addition of "Companion Diagnostics Development Services Market (2nd Edition), 2022-2035" report to its list of offerings.
The growing pipeline of patient-centric targeted therapies has led to a surge in demand for companion diagnostics; these tests are known to improve the success rates of late-stage trials by almost three-fold. The development and approval of these FDA classified high-risk devices requires multidisciplinary expertise and an established network of…
More Releases for Therapeutics
Digital Therapeutics Market, Digital Therapeutics Market Size, Digital Therapeut …
The global digital therapeutics market is expected to reach US$ 8,941.1 Mn by 2025 from US$ 1,993.2 Mn in 2017. The market is estimated to grow with a CAGR of 20.8% during the forecast period from 2018 to 2025.
North America is the largest geographic market and it is expected to be the largest revenue generator during the forecast period, whereas the market is expected to witness growth at a significant…
Pruritus Drug Market – Key Players are Cara Therapeutics, Enteris BioPharma, N …
The Pruritus Drug Market research report is a significant investigation of changing business sector elements, driving elements, impediments, and limitations that have been considered the most extensive impacts on market development. Adroit investigative devices, for example, Porter’s Five Forces examination, SWOT examination, and Feasibility examination study have likewise been utilized by the report to offer an exhaustive information of the market. It will go about as a key research report…
Dravet Syndrome Therapeutics- Pipeline Analysis 2018 | Zogenix, Inc., Ovid Thera …
Dravet syndrome is a form of severe myoclonic epilepsy that occurs in infants during their first year of age. If left untreated, it can be associated with other types of seizures, and status epilepticus. Children having Dravet syndrome are generally observed with poor cognitive skills and hyperactivity.
Download the sample report @ https://www.pharmaproff.com/request-sample/1098
It severely affects the person’s quality of life and around 10-20% of the patient are estimated to die due…
Global mRNA Cancer Vaccines and Therapeutics Market to 2025| Moderna Therapeutic …
Researchmoz added Most up-to-date research on "Global mRNA Cancer Vaccines and Therapeutics Market Size, Status and Forecast 2019-2025" to its huge collection of research reports.
mRNA Cancer Vaccines and Therapeutics Market report includes (6 Year Forecast 2019-2025) includes Overview, classification, industry value, price, cost and gross profit. It also offers in-intensity insight of the mRNA Cancer Vaccines and Therapeutics industry masking all vital parameters along with, Drivers, Market Trends, Market Dynamics,…
Global Pruritus Therapeutics Market Report 2019 Companies included Actavis, Trev …
Market Reports Company has recently published 7th edition of Pruritus Therapeutics Market Report which covers historic data of year 2013 to 2018 along with a forecast till year 2026.
For inquiry or free sample pages email us at: sales@marketreportscompany.com
The report provides a comprehensive view on the current state and future prospects of the market which analyzes different strategies for business growth. The global Pruritus Therapeutics market was valued at USD xx…
MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Mode …
WiseGuyReports.Com Publish a New Market Research Report On –“ MRNA Vaccines & Therapeutics Market 2019 Global Analysis By Key Players – Moderna Therapeutics, CureVac, Translate Bio, BioNTech, Sangamo Therapeutics, Argos Therapeutics”.
Description:-
The mRNA Vaccines & Therapeutics industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, mRNA Vaccines & Therapeutics market size to maintain the average annual growth rate of XXX from…